OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity
Chengsong Yan, Lin Zheng, Shutan Jiang, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1276-1293.e11
Closed Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 81

Tumor-secreted FGF21 acts as an immune suppressor by rewiring cholesterol metabolism of CD8+T cells
Cegui Hu, Wen Qiao, Xiang Li, et al.
Cell Metabolism (2024) Vol. 36, Iss. 3, pp. 630-647.e8
Closed Access | Times Cited: 27

Nutrients: Signal 4 in T cell immunity
Jana Raynor, Hongbo Chi
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 3
Open Access | Times Cited: 26

Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy
Yangkai Zhou, Jing Yuan, Ke Xu, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1846-1864
Closed Access | Times Cited: 20

Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia
Chaja F. Jacobs, Fleur S. Peters, Elena Camerini, et al.
Cellular and Molecular Immunology (2025)
Open Access | Times Cited: 3

Obesity reshapes regulatory T cells in the visceral adipose tissue by disrupting cellular cholesterol homeostasis
Cody Elkins, Chengyu Ye, Pulavendran Sivasami, et al.
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 2

The lipid basis of cell death and autophagy
Zhi Lin, Fei Long, Rui Kang, et al.
Autophagy (2023) Vol. 20, Iss. 3, pp. 469-488
Open Access | Times Cited: 40

Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Yannick Bulliard, Börje S. Andersson, Mehmet A. Baysal, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 28

CRISPR–Cas9 applications in T cells and adoptive T cell therapies
Xiaoying Chen, Shuhan Zhong, Yonghao Zhan, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 15

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment
Haixia Zhang, Shizhen Li, Dan Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 15

Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 14

Macrophages and T cells in metabolic disorder-associated cancers
Daniel Taranto, Daan J. Kloosterman, Leila Akkari
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9

Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, et al.
Immunological Reviews (2024) Vol. 323, Iss. 1, pp. 19-39
Closed Access | Times Cited: 8

Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
Wen G. Jiang, Weilin Jin, Aman Xu
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2044-2071
Open Access | Times Cited: 8

Targeting the mevalonate pathway potentiates NUAK1 inhibition-induced immunogenic cell death and antitumor immunity
Liming Gui, Kaiwen W. Chen, Jingjing Yan, et al.
Cell Reports Medicine (2025), pp. 101913-101913
Open Access | Times Cited: 1

CYP51A1 drives resistance to pH-dependent cell death in pancreatic cancer
Fangquan Chen, Hu Tang, Changfeng Li, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1

A functional single-cell metabolic survey identifies Elovl1 as a target to enhance CD8+ T cell fitness in solid tumours
Samantha Pretto, Qian Yu, Pierre Bourdely, et al.
Nature Metabolism (2025)
Open Access | Times Cited: 1

Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients
Jianzhou Chen, Antonin Lévy, Ai-Ling Tian, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 361-379.e10
Open Access | Times Cited: 1

Coengineering specificity, safety, and function into T cells for cancer immunotherapy
Greta Maria Paola Giordano Attianese, Sarah Ash, Melita Irving
Immunological Reviews (2023) Vol. 320, Iss. 1, pp. 166-198
Open Access | Times Cited: 17

Advances in reprogramming of energy metabolism in tumor T cells
Liu Xuekai, Yan Song, Jian Chu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7

Inhibition of DUSP18 impairs cholesterol biosynthesis and promotes anti-tumor immunity in colorectal cancer
Xiaojun Zhou, Genxin Wang, Chenhui Tian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6

Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment
Yucheng Zheng, Rongwei Xu, Xu Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 6

ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells
Tu-Xiong Huang, Hui-Si Huang, Shaowei Dong, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Regulation of CD8+ T cells by lipid metabolism in cancer progression
Yong Tang, Ziqing Chen, Qianying Zuo, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1215-1230
Open Access | Times Cited: 5

Ferroptosis resistance in cancer: recent advances and future perspectives
Zhang Xing, Xiang Li, Xia Ran, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115933-115933
Closed Access | Times Cited: 11

Page 1 - Next Page

Scroll to top